Publication
Pfizer company outlook: a "Covid-19 dependent" business?
| Summary: | This equity report aims at analyzing and evaluating the pharmaceutical company Pfizer in a context of the global pandemic and the possible outcomes of the post-pandemic. We also researched the latest industry trends and analyzed the pharma regulation, M&A activity, patents, and emerging technologies. Thorough the report, we explained the methodologies and how recent industry and economic factors will affect the revenues of the main Pfizer’s pharmaceutical products |
|---|---|
| Main Authors: | Arias, David |
| Subject: | Valuation Innovation R&D Healthcare Covid Vaccines Patents Oncology |
| Year: | 2022 |
| Country: | Portugal |
| Document type: | master thesis |
| Access type: | open access |
| Associated institution: | Universidade Nova de Lisboa |
| Language: | English |
| Origin: | Repositório Institucional da UNL |
| Summary: | This equity report aims at analyzing and evaluating the pharmaceutical company Pfizer in a context of the global pandemic and the possible outcomes of the post-pandemic. We also researched the latest industry trends and analyzed the pharma regulation, M&A activity, patents, and emerging technologies. Thorough the report, we explained the methodologies and how recent industry and economic factors will affect the revenues of the main Pfizer’s pharmaceutical products |
|---|